Phenotypic and Genotypic Characterization of New-onset Type I Diabetes — DIATAG  

Type1diabetes Clinical Trial

Official title: Phenotypic and Genotypic Characterization of a Cohort of Pediatric Patients With New-onset Type 1 Diabetes

Status Active, not recruiting

Clinical Trial Summary

The goal of DIATAG study is the identification of biomarkers of T1D evolution in a pediatric cohort.

Clinical Trial Description

Type 1 diabetes (T1D) is a common chronic disease in childhood. Clinical presentation at onset of T1D can vary among patients from long-standing diabetes triad symptoms (polyuria, polydipsia and weight loss) to coma and ketoacidosis. The initial clinical presentation of T1D was shown to have long-term influence on glycemic control of the patient. The investigators initiated a collaborative consortium including six pediatric clinics in Belgium to better characterize new-onset T1D patients.

Hypothesis :

1. Different subgroups of T1D patients might exist, underlying different physiopathology of T1D :

• The investigators will first investigate the presence of biomarkers in different fluids (e.g. urine, blood, feces,...).

• The investigators will correlate results with clinical parameters of glycemic control. Dynamic tests (HOMA and stimulated C peptide) will be realized at 2 defined time points of the follow-up.

2. Glucose variability can be influenced by external factors (e.g. diet, physical activity, Quality of Life (QoL),...) The investigators will evaluate those external factors using approved questionnaires. They will presented to the patient and its parents at 2 defined time points. ;

Related Conditions & MeSH terms

• Diabetes Mellitus
• Diabetes Mellitus, Type 1
• Type1diabetes

• NCT number: NCT04007809
• Study type: Interventional
• Source: Université Catholique de Louvain
• Status: Active, not recruiting
• Phase: N/A
• Start date: June 15, 2019
• Completion date: June 30, 2027